From GlobeNewswire:

TG Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. The presentation by CEO Michael S. Weiss will begin at 4:30 PM PT and can be viewed live on TG Therapeutics’ website. The company focuses on acquiring, developing, and commercializing treatments for B-cell diseases, including FDA-approved BRIUMVI® for relapsing forms of multiple sclerosis. For more information, visit www.tgtherapeutics.com.



Read more: TG Therapeutics to Participate in the 42nd Annual J.P.